Maryland Matters
By: Bruce DePuyt
May 9, 2020


“The architects of the state’s fledgling Prescription Drug Affordability Board are urging the General Assembly to override Gov. Lawrence J. Hogan Jr.’s veto of a measure to fund the panel’s operations.

Senate Bill 669 and House Bill 1095 would set up a funding source for the panel, which was created in 2019 and began meeting for the first time this year.

The board was established by lawmakers to identify ways of reducing the cost of prescription drugs, an issue that consumers and policymakers have said is a major obstacle to improving health care outcomes.”

Read the full article.

Last modified: May 9, 2020